key: cord-0754511-2wdyuasp authors: van de Sand, L.; Bormann, M.; Alt, M.; Schipper, L.; Heilingloh, C.S.; Todt, D.; Dittmer, U.; Elsner, C.; Witzke, O.; Krawczyk, A. title: Glycyrrhizin effectively neutralizes SARS-CoV-2 in vitro by inhibiting the viral main protease date: 2020-12-20 journal: bioRxiv DOI: 10.1101/2020.12.18.423104 sha: 9da818fd1aebd8af495abe583c7f6dcf3a524e6b doc_id: 754511 cord_uid: 2wdyuasp The newly emerged coronavirus, which was designated as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of the COVID-19 disease. High effective and well-tolerated medication for hospitalized and non-hospitalized patients is urgently needed. Traditional herbal medicine substances were discussed as promising candidates for the complementary treatment of viral diseases and recently suggested for the treatment of COVID-19. In the present study, we investigated aqueous licorice root extract for its neutralizing activity against SARS-CoV-2 in vitro, identified the active compound glycyrrhizin and uncovered the respective mechanism of viral neutralization. We demonstrated that glycyrrhizin, the primary active ingredient of the licorice root, potently neutralizes SARS-CoV-2 by inhibiting the viral main protease. Our experiments highlight glycyrrhizin as a potential antiviral compound that should be further investigated for the treatment of COVID-19. The newly emerged coronavirus, which was designated as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of the COVID-19 disease. Even presymptomatic patients or patients with mild symptoms are able to infect other people. Highly effective and well-tolerated medication for hospitalized and non-hospitalized patients is urgently needed. Besides compounds that were initially approved for the treatment of other viral infections such as remdesivir 1 , traditional herbal medicine substances were discussed as promising candidates for the complementary treatment of viral diseases and recently suggested for the treatment of COVID-19. In the present study, we investigated aqueous licorice root extract for its neutralizing activity against SARS-CoV-2 in vitro, identified the active compound glycyrrhizin and uncovered the respective mechanism of viral neutralization. Dried licorice roots were brewed in PBS at a concentration of 8 mg/ml (w/v) and the fluid was subsequently sterile filtered to obtain an aqueous licorice root extract. The neutralization capacity of licorice root extract was determined in cell culture by endpoint dilution. For this purpose, serial dilutions of the licorice root extract (0.004 mg/ml -4 mg/ml) were pre-incubated with 100 TCID50 of SARS-CoV-2 for 1 hour at 37 °C and subsequently incubated on confluent Vero E6 cells grown in 96-well microtiter plates (pre-entry approach). After 48 hours, the cells were stained with crystal violet and analysed for plaque formation. Cytotoxicity was determined at four distinct time points (5 minutes, 12 hours, 24 hours and 4 hours) by using the "Orangu cell counting solution" (Cell guidance systems, Cambridge, United Kingdom), which is a WTS-8 based assay using NAD(P)H concentration and dehydrogenase enzyme activity to detect the cell vitality. The aqueous licorice root extract showed neutralizing effects even at a subtoxic concentration of 2 mg/ml, ( Figure 1A and B). This concentration is lower than the normal consuming dilution e.g. in tea (12.5 mg/ml). Although licorice root tea may represent a good candidate for complementary use, the identification and characterization of the active compound is of great importance for a potential clinical application. Glycyrrhizic acid is a triterpene saponin and found in high concentrations in the root of the Glycyrrhiza glabra plant. It was described as an antiviral active ingredient of the licorice root and exhibits antiviral activity against herpes simplex viruses 2 , the human immunodeficiency virus as well as human and animal coronaviruses 3 . Lastly, an in-silico simulation study proposed an antiviral activity of glycyrrhizin against SARS-CoV-2, but this hypothesis remains experimentally unproved by now 4 . Based on our results with the aqueous licorice root extract, we investigated the antiviral activity of glycyrrhizin acid against a clinical SARS-CoV-2 isolate and subsequently examined the underlying mechanism of viral neutralization. The neutralizing activity of glycyrrhizin against a clinical SARS-CoV-2 isolate was investigated in cell culture. Here, glycyrrhizin acid ammonium-nitrate was dissolved in DMEM containing 2% (v/v) FCS and 1% penicillin-streptomycin at 37 °C and adjusted to pH 7. A potential cytotoxic effect of glycyrrhizin was investigated as described above. No cytotoxic effect could be observed even at a concentration of 4 mg/ml ( Figure 1B CoV-2 RNA was quantified by RT-qPCR. Therefore, primer targeting the viral M or N gene were used. M and N gene copy numbers were assessed using a 1:10 plasmid dilution series as reference (details and sequence information available upon request). Glycyrrhizin treatment significantly reduced the genomic SARS-CoV-2 RNA levels ( Figure 1D) . Taken together, we demonstrated that glycyrrhizin exhibited a high antiviral activity against SARS-CoV-2. Next, we investigated the underlying mechanism how glycyrrhizin may interfere with the virus replication. Recently, protease inhibitory activity of glycyrrhizin was predicted by in silico simulations 5 . The human transmembrane serine protease (TMPRSS2) was shown to cleave the SARS-CoV-2 Spike protein thereby facilitating the virus entry into the host cell 6 . However, since there was only a slight difference in antiviral activity of glycyrrhizin between pre-and post-entry conditions, and only a minor affinity was simulated for the interaction between glycyrrhizin and TMPRSS2, we concluded that glycyrrhizin neutralizes the virus by a mechanism different from inhibiting TMPRSS2. Thus, we focused on the SARS-CoV-2 main protease (M pro ) as a potential target for glycyrrhizin 7 . M pro is essential for processing the viral polyproteins that are translated from the viral RNA and thus, for virus replication 7 . Glycyrrhizin was suggested as a possible inhibitor of M pro by in silico analysis, but this hypothesis has never been experimentally proven 5 Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro Inhibition of intercellular adhesion in herpex simplex virus infection by glycyrrhizin Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus Glycyrrhizin: An old weapon against a novel coronavirus Molecular Docking and ADMET Study of Bioactive Compounds of Glycyrrhiza glabra Against Main Protease of SARS-CoV2 SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors Glycyrrhizic acid: the assessment of a no effect level A Review of the Pharmacological Efficacy and Safety of Licorice Root from Corroborative Clinical Trial Findings Glycyrrhetinic acid and its derivatives as potential alternative medicine to relieve symptoms in nonhospitalized COVID-19 patients This study was supported by the Stiftung Universitätsmedizin Essen (awarded to A. Krawczyk) and the Rudolf Ackermann Foundation (awarded to O. Witzke). The authors thank Barbara Bleekmann for excellent technical assistance.